Regional ventilation–perfusion changes after endobronchial valve therapy assessed by single-photon emission computed tomography in adults with severe COPD

Bronchoscopic lung volume reduction (BLVR) is an established treatment for patients with severe chronic obstructive pulmonary disease (COPD), characterized as emphysema and hyperinflation, but current methods of patient selection and lobe identification are limited due to invasiveness, lack of specificity, and poor regional ventilation and perfusion assessments. This study aimed to evaluate lobar changes in ventilation, perfusion, and volume before and after endobronchial valve (EBV) placement using SPECT/CT imaging in patients with severe emphysema, and to assess their association with clinical outcomes. A prospective, single-center, pilot study enrolled six patients with severe COPD (FEV<sub>1</sub> ≤ 50%), and hyperinflation on pulmonary function tests (PFTs). Additionally, participants had severe heterogeneous emphysema (≥ 70% with voxel density ≤ - 910 Hounsfield units), and adequate fissure integrity (≥ 95%), both quantified by StratX™. All participants underwent BLVR in a single target lobe and received pre- and post-procedure SPECT/CT imaging using nebulized <sup>99m</sup>Tc inhaled in the upright position to assess ventilation followed by <sup>99m</sup>Tc-macroaggregated albumin injection to assess perfusion. Ventilation, perfusion, and volume were quantified at the target, adjacent, and contralateral lobes using AutoLung 3D software. PFTs and six-minute walk tests (6MWT) were obtained before and after BLVR. Treated lobes demonstrated a significant reduction in ventilation (66.7% [IQR 47.1-88.2]), perfusion (71.9% [63.1-78.8]), and volume (26.2% [10.4-35.3]) after BLVR. Adjacent lobes exhibited compensatory increases in ventilation (16.7% [8.5-51.3]), perfusion (+ 22.9% [19.7-33.9]), and volume (+ 12.6% [8.0-17.4]), while changes in contralateral lobes were minimal. These physiological changes weakly correlated with FEV<sub>1</sub> and 6MWT, which may suggest a disconnect between regional physiological adaptation and functional capacity. While prior studies have evaluated baseline physiology with SPECT/CT prior to BLVR, this is the first study to use this novel imaging to assess physiological responses after BLVR. SPECT/CT is a promising tool for evaluating lobar-level physiological responses to BLVR. Larger, multicenter studies with long-term follow-up are needed to validate its utility in patient selection, procedural planning, and outcome prediction following BLVR.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-01-13
DOI
https://doi.org/10.1038/s41598-026-35460-2
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regional ventilation–perfusion changes after endobronchial valve therapy assessed by single-photon emission computed tomography in adults with severe COPD

K.B. Nakrani, Bruce Spottiswoode, TRISHUL SIDDHARTHAN, Consultant Physician Partha Ghosh et al.
Scientific Reports
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Regional ventilation–perfusion changes after endobronchial valve therapy assessed by single-photon emission computed tomography in adults with severe COPD

K.B. Nakrani, Bruce Spottiswoode, TRISHUL SIDDHARTHAN, Consultant Physician Partha Ghosh, KENEDIE ST. MARY, Dipan Karmali, Michael Lester, Sixto Arias, Gabrielle Aguilar, Naresh Punjabi
article en

Abstract

Bronchoscopic lung volume reduction (BLVR) is an established treatment for patients with severe chronic obstructive pulmonary disease (COPD), characterized as emphysema and hyperinflation, but current methods of patient selection and lobe identification are limited due to invasiveness, lack of specificity, and poor regional ventilation and perfusion assessments. This study aimed to evaluate lobar changes in ventilation, perfusion, and volume before and after endobronchial valve (EBV) placement using SPECT/CT imaging in patients with severe emphysema, and to assess their association with clinical outcomes. A prospective, single-center, pilot study enrolled six patients with severe COPD (FEV<sub>1</sub> ≤ 50%), and hyperinflation on pulmonary function tests (PFTs). Additionally, participants had severe heterogeneous emphysema (≥ 70% with voxel density ≤ - 910 Hounsfield units), and adequate fissure integrity (≥ 95%), both quantified by StratX™. All participants underwent BLVR in a single target lobe and received pre- and post-procedure SPECT/CT imaging using nebulized <sup>99m</sup>Tc inhaled in the upright position to assess ventilation followed by <sup>99m</sup>Tc-macroaggregated albumin injection to assess perfusion. Ventilation, perfusion, and volume were quantified at the target, adjacent, and contralateral lobes using AutoLung 3D software. PFTs and six-minute walk tests (6MWT) were obtained before and after BLVR. Treated lobes demonstrated a significant reduction in ventilation (66.7% [IQR 47.1-88.2]), perfusion (71.9% [63.1-78.8]), and volume (26.2% [10.4-35.3]) after BLVR. Adjacent lobes exhibited compensatory increases in ventilation (16.7% [8.5-51.3]), perfusion (+ 22.9% [19.7-33.9]), and volume (+ 12.6% [8.0-17.4]), while changes in contralateral lobes were minimal. These physiological changes weakly correlated with FEV<sub>1</sub> and 6MWT, which may suggest a disconnect between regional physiological adaptation and functional capacity. While prior studies have evaluated baseline physiology with SPECT/CT prior to BLVR, this is the first study to use this novel imaging to assess physiological responses after BLVR. SPECT/CT is a promising tool for evaluating lobar-level physiological responses to BLVR. Larger, multicenter studies with long-term follow-up are needed to validate its utility in patient selection, procedural planning, and outcome prediction following BLVR.

Scientific ReportsVol. 16(1)
University of Miami (US), Siemens (United States) (US), Vanderbilt University Medical Center (US)
National Institutes of Health, National Heart, Lung, and Blood Institute
No poverty
Openalex Percentile: Top 90%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.